The PurpleLab^® Resource Center

Featured Resources

Life Sciences

Driving Clinical Trial Recruitment Through a Targeted HCP Omnichannel Approach

Over the last decade, the life sciences industry has used digital advertising at an increasing rate to engage with patients throughout the drug development life cycle. From creating disease state awareness, to driving drug adherence, the trend particularly accelerated during 2020 and 2021, as pharmaceutical brands looked for ways to stay engaged with their patients…

Understanding Patient and Provider Treatment Patterns in Challenging High-Cost Diseases

In 2019, the National Multiple Sclerosis Society published a series of findings with updated prevalence of the disease. Current estimates place the number of people diagnosed with Multiple Sclerosis (MS) at one million people in the US; double previously reported figures. It is a costly and chronic disease without an exact known cause or biomarker,…

Using Real-World Data to Better Understand Biosimilar Adoption Variation Across Providers

February is low-vision month, and at PurpleLab we are focusing on Age-Related Macular Degeneration (AMD), one of the diseases responsible for this condition. According to the Centers for Disease Control’s (CDC) Vision and Eye Health Surveillance System (VEHSS) about twenty million Americans aged forty and older are living with AMD; 1.5 million of which are…